Syndax Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Syndax (SNDX)GuruFocus · Oct 13, 2026
Celea Therapeutics Will Present Phase 3 Trial Design for Idiopathic Pulmonary Fibrosis and Key Insights from a Deupirfenidone Drug-Drug Interaction Study at the Upcoming European Respiratory Society (GuruFocus · Aug 25, 2026
PureTech Founded Entity Celea Therapeutics to Deliver Two Presentations at the Upcoming European Respiratory Society (ERS) CongressGuruFocus · Aug 25, 2026This exchange-traded fund is constructed to largely replicate the financial performance, including both capital growth and income returns, of the Dorsey Wright Dynamic Focus Five Index. This target is aimed for prior to the deduction of the fund's own operating expenses and charges.